Biotech Week articles from March 2002

Biotech Week archives from March 2002

Blood test may catch disease in early stages.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- A sensitive and noninvasive computer-assisted technique that assesses proteomic patterns in blood could be a step toward effective screening for ovarian cancer, conclude authors of a fast-track study...

North Carolina trying to lure medicinal tobacco research company.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- North Carolina is trying to lure a biotech company from Virginia that develops genetically modified tobacco for medicine, a move officials said could increase demand for the leaf. Economic...

AVANIR Pharmaceuticals expands docosanol distribution through licensing agreement.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- AVANIR Pharmaceuticals (AVN) has established a license agreement with Biopharm Group to manufacture and market docosanol 10% cream in Egypt, select countries of the Middle East and the Gulf Cooperative...

Multiantigen vaccine with recombinant gp160 effective in newly infected patients.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers say that a multiantigen HIV vaccine, administered with recombinant gp160, can improve antiviral immune responses in acutely infected patients. ...

January is disappointing for biotech stocks.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- After a strong recovery in the final quarter of 2001, biotech got off to a lackluster start in 2002 with the biggest product deal in biotech's history getting off track (ImClone/Bristol-Myers Squibb)...

Collaboration will improve phosphorus management among dialysis patients.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Genzyme General (GENZ) and Gambro Healthcare, Inc., a wholly owned subsidiary of Gambro AB (GAMBaST), announced the launch of a comprehensive program designed to improve phosphorus management among...

FDA advisory committee recommends approval of Novartis drug Zometa.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Novartis announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) recommended approval of Zometa (zoledronic acid for injection) for the treatment of...

New alliance has basis in gene discovery collaboration.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Roche and deCODE genetics, Inc,. (DCGN) announced the formation of a new, 3-year alliance focused on turning the landmark achievements of their gene discovery collaboration into novel treatments for...

David F. Erinakes promoted to vice president of sales.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Cyberonics, Inc., (CYBX) announced that David F. Erinakes has been promoted from national sales director to vice president of sales responsible for U.S. sales. Erinakes has over 10 years of...

Dianon systems anticipates increased revenue.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Dianon Systems, Inc., (DIAN), a leading national provider of cancer and genomic diagnostic services, announced that, based on preliminary results, the Company anticipates that its revenue and net...

Aruffo to succeed retiring Kamen.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories announced it has appointed Alejandro Aruffo, PhD, as president, Abbott Bioresearch Center (ABC), and divisional vice president, Abbott Laboratories. Aruffo, formerly vice...

Additions to management team announced.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc. (ABRX) announced several new appointments to its management team with the hire of additional personnel in various positions. The new employees support the Company's continuing...

Company reports financial results for 4Q, fiscal year.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) reported record results for its fourth quarter and fiscal year 2001. Product revenue increased to $55.2 million for the fourth quarter up from $51.3 million for the comparable...

Cancer vaccine receives FDA fast track designation.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Antigenics Inc. (AGEN) announced that the U.S. Food and Drug Administration (FDA) has granted the company's personalized cancer vaccine, Oncophage (HSPPC-96), fast track designation for the treatment of...

Record fourth quarter sales achieved.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. (AICX) announced that it has achieved its fourth consecutive quarter of record revenues. Preliminary sales for the fourth quarter of $5.25 million were 13% ahead of last...

Neuron subtype-specific cDNAs offer precision, convenience for gene expression research.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Arcturus has introduced five new Cellex Mouse Neuron cDNAs - providing convenience and precision in gene expression or discovery studies of the mouse brain. Polymerase chain reaction (PCR) of cDNA...

2Q 2002 EPS of $0.91 reported.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) reported net earnings of $42.1 million, or $0.91 per share on a fully diluted basis for the second quarter of fiscal 2002, ended December 31, 2001. For the first 6...

Approval received for generic versions of Prozac.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc. (BRL), has received approval from the U.S. Food and Drug Administration (FDA) for Fluoxetine Tablets, 10 mg, the generic equivalent of Lilly's Prozac tablets. The company...

Berna Biotech teams with IAVI, Gallo lab, Uganda for test.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Swiss vaccine manufacturer Berna Biotech, Ltd., has joined a cross-national team to test a new vaccine to prevent HIV infection and AIDS designed specifically for use in developing countries. Berna...

Brand management: Building profits through customer communication.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- As many global pharmaceutical companies struggle to build a consistent brand identity that appeals to disparate markets, world-class companies focus on improving the total customer experience as a key...

Merck's affiliate opens office in U.S.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Merck KGaA announced that its affiliate Biovation, Ltd., of Aberdeen, U.K., has expanded its operations by opening a U.S. office in Research Triangle Park, North Carolina. Biovation's contact...

Cambrex names chief technology officers of biotechnology and pharmaceutical technologies.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Cambrex Corporation (CBM) announced the appointment of Daniel R. Marshak, PhD, to the position of vice president and chief technology officer, biotechnology, and of Ron Carroll, PhD, to the position of...

Company issues update, annual general meeting statement.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology issued the following statement: Since our report to shareholders in late November, we have continued to build on our achievements of last year. We have announced two...

Ongoing litigation settled.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Celsion Corp. (CLN) announced that it has settled its ongoing lawsuit with Warren C. Stearns and his associates. Under the terms of the settlement, Celsion issued to the Stearns group certain...

Total revenues exceed $1 billion.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) reported pro forma income from continuing operations of $187 million or $0.96 per share for the year ended December 31, 2001. This represents an increase over the $170 million, or...

First milestone achieved in agreement for CD46 human antibodies against cancer.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell N.V. (CRXL), announced that the first milestone has been achieved under its agreement with Centocor, Inc. The milestone was one of the agreed-upon goals for...

Company's initial public offering filed.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., announced that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. DOV...

Comprehensive platform being developed for chemoinformatics.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- De Novo Pharmaceuticals (De Novo) and Sun Microsystems have announced a joint technology development initiative to codevelop a comprehensive chemoinformatics platform. De Novo and SUN will pool...

Notice for core epitope technology received.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office covering core technology for the identification and enhancement or elimination of...

Robert Myers named as executive VP.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Exelixis, Inc., (EXEL) announced that Robert M. Myers has joined the executive management team as executive vice president, Pharmaceuticals. Myers will be responsible for building Exelixis'...

Pharmacogenomics Collaboration Targets Biogen's Investigational Drugs.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Genaissance Pharmaceuticals, Inc., (GNSC) has entered into an agreement with Biogen, Inc., (BGEN) in which the companies will apply Genaissance HAP Technology to drugs currently in development and to...

Which came first, the cow or the sheep?
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Which came first, the cow or the sheep, i.e., Gene or Dolly? That is one of the questions that will be considered by the U.S. Patent Office in what is shaping up as the ultimate battle over who owns...

Third quarter revenues up 24%.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- IGEN International, Inc., (IGEN), owner of the proprietary ORIGEN technology platform for biological detection, reported that revenue in its third fiscal quarter, which ended December 31, 2001,...

Strategic alliance to link cancer treatment network with tumor registry software.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Impath, Inc., (IMPH) and Varian Medical Systems, Inc., (VAR) announced a strategic alliance for the development of software interfaces linking radiation and medical oncology databases with tumor...

Company prioritizes pipeline to focus on ophthalmology, respiratory areas.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Inspire Pharmaceuticals, Inc., (ISPH) will announce at the US Bancorp Piper Jaffray Health Care Conference in New York City that, based on the recently reported Phase III dry eye study results, the...

InterMune relaunches Infergen for hepatitis C infections.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- InterMune, Inc.. (ITMN) has relaunched Infergen (Interferon alfacon-1) for the treatment of chronic hepatitis C infections. Effective immediately, InterMune's recently expanded sales force will...

Company announces $13.9M private placement.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- IntraBiotics Pharmaceuticals, Inc., (IBPI) announced that it has entered into definitive purchase agreements to sell 5.9 million shares of newly issued common stock in a private placement to selected...

Clinical, pharmacologic research acquisition complete.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Kendle International, Inc., (KNDL), a leading full-service contract research organization, announced its acquisition of Clinical and Pharmacologic Research, Inc. CPR is located in Morgantown, West...

Unique database of known drugs in production.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- LeadScope, Inc., announced that a new and unique database of known drugs is in production and will be released in April 2002. The new structure-searchable Known Drugs database includes marketed...

New partnership will increase availability of allograft.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- LifeCell Corp. (LIFC), a leader in developing and commercializing biologically based solutions to repair or replace the body's damaged tissue, has entered into an agreement with LifeNet, the largest...

Atlanta newspaper admits error in Metabolife/Poynter story.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- The following is being issued by Metabolife International, Inc.: The Atlanta Journal-Constitution (AJC) refused to acknowledge that it had falsely implied that the diet supplement, Metabolife, had...

Major advance in nanomaterial development reported.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Nanosys, Inc., reported on the publication of a journal article in the February 2002 issue of NanoLetters by Peidong Yang, Nanosys cofounder and a Professor of Chemistry at the University of California...

2001 hospital implementation goal exceeded.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- In a company presentation to institutional investors attending the UBS Warburg Global Healthcare Services Conference in New York, the management of Neoforma, Inc., (NEOF) reported that Neoforma...

Partner Merz Pharma honored for work on Memantine.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Neurobiological Technologies, Inc., (NTII) announced that its strategic partner, Merz Pharma KGaA, has been honored for its work on Memantine and granted the German Innovation Award 2002. NTI and Merz...

Global BioDevelopment consulting practice launched.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Parexel International Corp. (PRXL), one of the world's largest biopharmaceutical outsourcing companies, announced that it now provides BioDevelopment Consulting Services in support of emerging, virtual,...

British biotech firm achieves high growth in United States.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- New technology, increasing demand for its drug delivery evaluation processes and regional drug absorption studies have helped Pharmaceutical Profiles increase levels of business in the United States by...

eResearchTechnology announces partnership agreement.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) (ERES) a leading provider of centralized electrocardiogram (ECG) collection and interpretation services, announced a partnership agreement with Pharmacia Corp., a...

Second quarter, six-month results released.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc., (PCYC) reported financial results for its second quarter ended December 31, 2001. The net loss for the period was $11,724,000, or $0.73 per share, compared with a net loss of...

Company announces staff promotions.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Progenics Pharmaceuticals, Inc., (PGNX) announced the promotions of Thomas A. Boyd, PhD, to the position of vice president, preclinical development and project management, and Philip K. Yachmetz to vice...

New treatment uses radiation alternative.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Learning she had breast cancer was bad enough for 40-year-old Marian Norton. Almost as troubling was the burden of 6 weeks of radiation treatment. The mother of two young children didn't like the...

Genomics ArrayPlate kits incorporated into Multi Parameter high throughput screening system.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Psychiatric Genomics, Inc., and High Throughput Genomics, Inc., are pleased to announce an alliance that will incorporate HTG's Multiplexed Molecular Profiling ArrayPlate Kits and Omix Imager into...

Companies enter strategic commercialization agreement for Niaspan, Advicor.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Quintiles Transnational Corp. (QTRN) announced the signing of an agreement with Kos Pharmaceuticals, Inc., to commercialize Advicor (extended-release niacin/lovastatin) and Niaspan (extended-release...

CRO celebrates fourth year of growth.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Regulatory/Clinical Consultants, Inc., (RxCCI), a contract research organization (CRO) based in Lee's Summit, Missouri, begins its fifth year of operation in February 2002. RxCCI is one of the fastest...

4Q, year end 2001 financial results.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) reported financial results for the fourth quarter and year ended December 31, 2001. The company reported revenues from collaborations of $4.8 million in the...

Company reports updates on loratadine suits.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- In response to media inquiries, Schering-Plough Corp. (SGP) said it has sued McNeil Consumer Healthcare and Whitehall-Robins Healthcare for filing applications with the U.S. Food and Drug Administration...

Strengthened financial situation, Kinetin commercial success highlighted.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Senetek PLC (SNTKY), a biopharmaceutical company that develops products in two key markets, sexual dysfunction and skin care/dermatologicals, at its annual meeting on January 29 in New York detailed the...

TheraSense announces estimated 2001 fourth quarter and full year results.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- TheraSense, Inc., (THER) a leader in glucose monitoring, and maker of the popular, virtually pain-free FreeStyle system, announced estimated results for its fourth quarter and year ended December 31,...

Company completes $3.8M private offering.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Thuris Corp. announced the completion of a $3.8 million private offering of preferred stock to an international group of investors and a codevelopment and services agreement with the lead investor,...

Founder, CEO of pharmaceutical company passes away.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Triangle Pharmaceuticals, Inc., (VIRS) announced the death of David Barry, 58, founder and chief executive officer of the company. Chris Rallis, Triangle's chief operating officer said "We are...

Acquisition of Biopool Hemostasis business complete.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Trinity Biotech plc (TRIB) announced the successful completion of the acquisition of the Biopool Hemostasis division of Xtrana, Inc., and the commencement of a restructuring program for this business....

Regulatory affairs, QA personnel hired.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN) announced the hiring of two professionals with distinguished track records to help the company submit its AIDS vaccine for regulatory approval if the vaccine, AIDSVAX, proves...

CEO sets milestones to present at BIO industry conference.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- The following is a letter from the CEO of Viragen, Inc., (VRA) and Viragen International, Inc., (VERP). In addition to these comments, stockholders are referred to the company's Form 10-K and Form 10-Q...

4Q, annual sales earnings released.
March 6, 2002... 2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Zimmer Holdings, Inc., (NYSE: ZMH) announced sales and earnings for the quarter and full-year ended December 31, 2001. Net sales for the fourth quarter increased 14% (16% constant currency) to $311.6...

Vaccine reduces bloodstream infections by nearly 60%.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- A single injection of a first-of-its-kind experimental vaccine, Nabi StaphVAX (Staphylococcus aureus polysaccharide conjugate vaccine), reduced bloodstream infections caused by the often drug-resistant...

Researchers engineer first 'custom-made' human knee ligaments from adult stem cells.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Researchers from Tufts University have developed a tissue engineering strategy to repair one of the most common knee injuries - ruptured anterior cruciate ligaments (ACL) - by mechanically and...

Computer company touts BLAST software for accelerating protein and DNA searches.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Apple has announced a breakthrough implementation of BLAST software that accelerates protein and DNA searches used in biomedical research and drug discovery. Apple/Genentech BLAST is up to five times...

New drugs show promise.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Despite dozens of failed studies, experimental new drugs designed to protect the brain from self-destruction after a stroke may lead to useful treatments after all, new data suggest. The search...

First orthopedic procedure performed with brain surgery technology.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Odin Medical Technologies, Inc., reported that PoleStar N-10, a compact intraoperative Magnetic Resonance Image (iMRI) Guidance System for neurosurgery procedures, was used for the first time during an...

Human stem cells transformed into mouse heart cells.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Researchers have transformed human adult bone marrow stem cells into mouse heart muscle cells that remained healthy and functioning in mice for more than 2 months. The findings may eventually...

Pneumococcal vaccine boosters less effective for HIV patients.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Booster doses of a commonly used vaccine against pneumococcal infections are markedly less effective in patients infected with HIV, researchers in the United...

Ikonisys, Inc., forms partnership with diagnostic imaging company.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Ikonisys, Inc., has granted The Bracco Group a license to use and market Ikonisys' impending noninvasive test for the detection of Down syndrome. In return, Bracco will become an equity investor in...

Andrew J. Perlman, MD, PhD, becomes CEO.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Affymax, Inc., a privately held biopharmaceutical company, has selected Andrew J. Perlman, MD, PhD, as chief executive officer. Dr. Perlman joins Affymax from Tularik, Inc., where he most recently...

Patent imminent on solid-dosage forms of interferon.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- After a 10-week delay caused by the anthrax threat to mail in Washington, DC, Amarillo Biosciences, Inc., (AMAR) expects to receive a patent for its oral formulation of interferon (alpha). "Now,...

Insurance and benefits company reports record fourth quarter and full year 2001.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Anthem, Inc., (ATH) a healthcare benefits and insurance company, reported that net income for the fourth quarter of 2001 increased 21% to $87.7 million, or $0.85 per share, compared with net income of...

Adult stem cells from knee fat turned into cartilage, bone, fat cells.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Duke University Medical Center researchers have reprogrammed adult stem cells taken from a small deposit of fat behind the kneecap into functioning cartilage, bone or fat cells that could potentially...

Company reports increased revenues in first quarter 2002.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Avanir Pharmaceuticals (AVN) reported a 21% increase in revenues during the first quarter of fiscal year 2002, which represents the 3 months ended December 31, 2001. Revenues increased to $6.1...

Company changes fiscal year, reports results for 6-month transition period.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Avigen, Inc., (AVGN) reported financial results for the end of a 6-month transition period resulting from the company's changing its fiscal year-end to December 31, 2001. At December 31, Avigen...

Companies collaborate on herbicide identification.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Paradigm Genetics, Inc., (PDGM) has delivered to Bayer AG (BAYZ) several high-throughput screening assays for the identification of new herbicides. Paradigm transferred the assays to Bayer's...

Shareholders approve increase in number of authorized shares.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO.A and BIO.B) has announced that all the proposals presented at a special meeting of its shareholders held February 4, 2002, were approved, including one to increase the...

Public/private partnership launches $60 million fundraising campaign.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- BioEnterprise Corp. has announced a $60 million fundraising campaign to support the organization's initiatives over the next five years. Under the board-approved commercialization plan, $35 million...

Company acquires laser facility in Germany.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Biolase Technology, Inc., (BLTI) has acquired a laser production facility near Munich, Germany, from Asclepion-Meditec AG (AFX). The new facility will supply the demand for Biolase's dental lasers...

Peter G. Tombros named to board of directors.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Cambrex Corp. (CBM) has added Peter G. Tombros to its board of directors. "Peter's pharma and biotech background complements our strategic direction of leveraging both chemical or small molecule,...

Eric S. Kentor to join board of directors.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- ChromaVision Medical Systems, Inc., (CVSN) has appointed Senior Healthcare Executive and Advisor Eric S. Kentor to serve on the company's board of directors. Kentor fills the vacancy left by...

Miguel S. Barbosa, PhD, selected to lead drug-discovery efforts.
March 20, 2002... 2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Chugai Biopharmaceuticals, Inc., has appointed Miguel S. Barbosa, PhD, as vice president of discovery biology. Dr. Barbosa will lead the direction and operation of the company's drug-discovery programs...